New 5, 6, 7, 8‐Tetrahydro‐Isoquinolines Bearing 2‐Nitrophenyl Group Targeting RET Enzyme: Synthesis, Anticancer Activity, Apoptotic Induction and Cell Cycle Arrest
Chemistry & Biodiversity · 2025
DOI: 10.1002/cbdv.202402758 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Abdelreheem A Saddik und 5 weiteren Autor:innen. Beteiligte Einrichtung: Chemistry Department, Faculty of Science, Assuit University, Assiut, Egypt. Hauptthemen laut MEDLINE: Apoptosis, Antineoplastic Agents, Cell Cycle Checkpoints, Tetrahydroisoquinolines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 77 Literaturangaben.
Abstract (Originalsprache)
In this work, we synthesized new 5, 6, 7, 8‐tetrahydroisoquinolines and 6, 7, 8, 9‐tetrahydrothieno[2, 3‐ c ]isoquinolines derivatives, and the structures of these new compounds were confirmed with different spectroscopic techniques. Furthermore, the anticancer activities of these compounds were assessed against eight tumor cell lines and one normal human skin fibroblast cell line ( HSF ). Subsequently, IC 50 values of the synthesized compounds were determined for two specific cancer cell lines. Compound 3 exhibited the most potent antiproliferative activity against the HEPG2 cell line, whereas compound 9c demonstrated superior efficacy against the HCT116 cell line. Moreover, the mechanism of action for compound 3 on HEPG2 cells using flow cytometry and Annexin V‐FITC apoptosis analysis was studied. Compound 3 caused cell cycle arrest at the G2/M with a 50‐fold increase in apoptosis of the HEPG2 cell line. Finally, a molecular docking study was conducted to assess the inhibitory potential of compounds 3 and 7 against the RET enzyme. Results indicated that compounds 3 and 7 bind to the RET enzyme with binding energies of −5.2 and −5.6 kcal/mol, respectively. Although these values suggest inhibitory activity, they are less potent than the standard inhibitor, alectinib , which exhibits a binding energy of −7.2 kcal/mol.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chemistry Department, Faculty of Science, Assuit University, Assiut, Egypt.
- Department of Materials Science and Engineering, National Yang-Ming Chiao Tung University (NYCU), Hsinchu, Taiwan.
- Chemistry Department, Faculty of Science, New Valley University, El-Kharja, Egypt.
- South Egypt Cancer Institute, Cancer Biology Depertment, Assuit University, Assiut, Egypt.
- Pharmacology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt.
ORCID-Profile: Etify A Bakhite, Eman M Sayed
Zitieren
APA
Saddik, A. A., Bakhite, E. A., Hassanien, R., Farhan, N., Sayed, E. M., & Sharaky, M. (2025). New 5, 6, 7, 8‐Tetrahydro‐Isoquinolines Bearing 2‐Nitrophenyl Group Targeting RET Enzyme: Synthesis, Anticancer Activity, Apoptotic Induction and Cell Cycle Arrest. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202402758
Vancouver
Saddik AA, Bakhite EA, Hassanien R, Farhan N, Sayed EM, Sharaky M. New 5, 6, 7, 8‐Tetrahydro‐Isoquinolines Bearing 2‐Nitrophenyl Group Targeting RET Enzyme: Synthesis, Anticancer Activity, Apoptotic Induction and Cell Cycle Arrest. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202402758
BibTeX
@article{Saddik2025,
author = {Saddik, Abdelreheem A and Bakhite, Etify A and Hassanien, Reda and Farhan, Naseer and Sayed, Eman M and Sharaky, Marwa},
title = {New 5, 6, 7, 8‐Tetrahydro‐Isoquinolines Bearing 2‐Nitrophenyl Group Targeting RET Enzyme: Synthesis, Anticancer Activity, Apoptotic Induction and Cell Cycle Arrest},
journal = {Chemistry & Biodiversity},
year = {2025},
doi = {10.1002/cbdv.202402758}
}
EUVIMED